IMDX
NASDAQ · Biotechnology
Insight Molecular Diagnostic
$3.18
-0.74 (-18.88%)
Open$3.82
Previous Close$3.92
Day High$3.99
Day Low$3.15
52W High$8.51
52W Low$2.42
Volume—
Avg Volume316.8K
Market Cap127.30M
P/E Ratio—
EPS$-1.49
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+447.5% upside
Current
$3.18
$3.18
Target
$17.41
$17.41
$14.05
$17.41 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.41M | 2.73M | 22.03M |
| Net Income | -54,628,509 | -30,414,882 | 4.29M |
| Profit Margin | -1,238.5% | -1,176.6% | 19.5% |
| EBITDA | -53,315,754 | -31,333,106 | 9.08M |
| Free Cash Flow | — | — | 3.08M |
| Rev Growth | +61.7% | +61.7% | +9.7% |
| Debt/Equity | — | — | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |